Target intelligence / Profile preview

Small nucleolar RNA SNORD18 (SNORD18)

Target
SNORD18
Molecular classification
Small nucleolar RNA, Non-coding RNA, C/D box snoRNA
01

Overview

Small nucleolar RNA SNORD18 (also called U18) is a non-coding RNA of the C/D box family, characterized by highly conserved C (UGAUGA) and D (CUGA) box sequence motifs[2][5]. It is located within the nucleolus, where it acts as a guide RNA to direct site-specific 2’-O-methylation of ribosomal RNA (rRNA) and some small nuclear RNAs (snRNAs) during the maturation of these RNAs, a process fundamental for the assembly and function of ribosomes in all eukaryotic cells[1][2][3][5]. Human SNORD18 is present in several closely related copies (SNORD18A, SNORD18B, SNORD18C), typically found in introns of genes encoding ribosomal proteins[2]. SNORD18 is essential for the correct chemical modification of rRNA, but there is no evidence that it functions as a direct therapeutic target, nor does it have a recognized role in human disease by itself[2][4][6]. Key points: - **Small nucleolar RNA SNORD18** is a non-coding RNA, *not* a protein, receptor, enzyme, or pharmacological target. - It guides **site-specific methylation** of rRNA for ribosome function[1][2][3][5]. - Not considered a drug target and not causally associated with any human disease[2][5][6]. - No known role as a **biomarker** or safety concern. This molecule is a housekeeping RNA essential for fundamental cellular processes, but it has no direct relevance as a therapeutic drug target.

Other names
U18SNORD18ASNORD18BSNORD18CLOC124903590
02

Mechanism of action

Not applicable. There are no drugs known to act via this RNA, and its function is not druggable in a conventional sense.

03

Biological functions

Ribosomal RNA modificationGuide RNA for site-specific 2’-O-methylation of rRNA and snRNARibosome biogenesis
04

Disease associations

SNORD18 itself (U18, also as SNORD18A/B/C) is not directly implicated as a causative factor in common human diseases; it is a member of a class of snoRNAs essential for ribosomal RNA maturation, with no direct evidence for involvement in specific pathologies[2][5]. (Note: Several closely related snoRNAs, such as SNORD118, have been implicated in rare neurological ribosomopathies, but SNORD18 is not among them[4][6].)
05

Safety considerations

None specific. As an essential factor in ribosomal RNA modification and ribosome biogenesis, global inhibition or genetic knockout of SNORD18 would be expected to be detrimental to cell viability, but this is not a therapeutic consideration at present.
06

Interacting drugs

None known. There are no established drugs known to target small nucleolar RNA SNORD18.
07

Biomarkers

None known. SNORD18 is not established as a clinical biomarker.

Beyond the preview

Go deeper on Small nucleolar RNA SNORD18 (SNORD18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORD18 (SNORD18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call